Primary cytoreductive surgery compared with neoadjuvant chemotherapy in patients with BRCA mutated advanced high grade serous ovarian cancer: 10 year survival analysis-Reference-Cited by-同舟云学术

Primary cytoreductive surgery compared with neoadjuvant chemotherapy in patients with BRCA mutated advanced high grade serous ovarian cancer: 10 year survival analysis

Published:2024-06 Issue:6 Volume:34 Page:879-885
ISSN:1048-891X
Container-title:International Journal of Gynecological Cancer
language:en
Short-container-title:International Journal of Gynecological Cancer

Author:

Kim Soyoun Rachel^ORCID,Parbhakar Ashna,Li Xuan,Bernardini Marcus Q,Hogen Liat,May Taymaa^ORCID

Publisher

Elsevier BV

Reference24 articles.

1. Annual report to the nation on the status of cancer, featuring cancer in men and women age 20-49 years;Ward;J Natl Cancer Inst,2019

2. Integrated genomic analyses of ovarian carcinoma;Cancer Genome Atlas Research Network;Nature,2011

3. Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer;Kim;J Ovarian Res,2019

4. Tailoring ovarian cancer treatment: implications of BRCA1/2 mutations;Madariaga;Cancers (Basel),2019

5. Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer;Bolton;JAMA,2012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival outcomes of primary vs interval cytoreductive surgery for International Federation of Gynecology and Obstetrics stage IV ovarian cancer: a nationwide population-based target trial emulation;American Journal of Obstetrics and Gynecology;2025-02

2. Limitations of CDX and PDX methods using for cultivation of malignant ovarian neoplasms and their mathematical justification;Surgery and Oncology;2024-11-29

3. Overall survival in ovarian cancer patients after cytoreductive surgery. A systematic review and meta-analysis;Current Problems in Surgery;2024-09